- Home
- IGC vs COCH Comparison
IGC vs COCH Comparison
Compare IGC & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IGC
- COCH
- Stock Information
- Founded
- IGC 2005
- COCH 1995
- Country
- IGC United States
- COCH United States
- Employees
- IGC N/A
- COCH N/A
- Industry
- IGC Biotechnology: Pharmaceutical Preparations
- COCH Blank Checks
- Sector
- IGC Health Care
- COCH Finance
- Exchange
- IGC Nasdaq
- COCH Nasdaq
- Market Cap
- IGC 29.4M
- COCH 29.8M
- IPO Year
- IGC N/A
- COCH N/A
- Fundamental
- Price
- IGC $0.31
- COCH $1.35
- Analyst Decision
- IGC Strong Buy
- COCH Strong Buy
- Analyst Count
- IGC 2
- COCH 3
- Target Price
- IGC $3.88
- COCH $8.00
- AVG Volume (30 Days)
- IGC 392.1K
- COCH 26.2K
- Earning Date
- IGC 02-18-2025
- COCH 04-01-2025
- Dividend Yield
- IGC N/A
- COCH N/A
- EPS Growth
- IGC N/A
- COCH N/A
- EPS
- IGC N/A
- COCH N/A
- Revenue
- IGC $1,236,000.00
- COCH $278,000.00
- Revenue This Year
- IGC N/A
- COCH N/A
- Revenue Next Year
- IGC $18.34
- COCH $19.76
- P/E Ratio
- IGC N/A
- COCH N/A
- Revenue Growth
- IGC 1.64
- COCH 15.35
- 52 Week Low
- IGC $0.26
- COCH $1.21
- 52 Week High
- IGC $0.91
- COCH $8.60
- Technical
- Relative Strength Index (RSI)
- IGC 52.84
- COCH 43.07
- Support Level
- IGC $0.26
- COCH $1.28
- Resistance Level
- IGC $0.34
- COCH $1.47
- Average True Range (ATR)
- IGC 0.02
- COCH 0.13
- MACD
- IGC 0.01
- COCH 0.00
- Stochastic Oscillator
- IGC 65.88
- COCH 25.42
About IGC IGC Pharma Inc.
IGC Pharma Inc develops advanced cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome and chronic pain. The company has two investigational drug assets targeting Alzheimer's disease, IGC-AD1 and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles. IGC-AD1 is a low-dose tetrahydrocannabinol-based formulation that is in a 146-person Phase 2 clinical trial for agitation in dementia due to Alzheimer's. IGC also markets a wellness brand, Holief, that targets women experiencing premenstrual syndrome and menstrual cramps.
About COCH Envoy Medical Inc.
Envoy Medical Inc is a hearing health company focused on providing innovative medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life.